STO-CSCO Joint Symposium
Designed for cancer patient care as well as the clinical research community, the STO-CSCO Joint Symposium focuses on recent advances in immuno-oncology and offers insights into their clinical applications.
For CSCO members looking for a foundational but comprehensive understanding of immunology, the meeting helps to contextualize the educational content by addressing current challenges, including the assessment of response and progression and the management of toxicity, and illustrating the role of immunotherapy with real-world data.
This symposium encourages open dialogue and provides a networking opportunity for faculty members and attendees to engage.
In 2022 and onward, this Symposium undertakes a comparative analysis of the regulatory requirements for the proper conduction of cancer clinical trials with an aim to harmonize both the high standards needed for cancer clinical trial design, as well as the rigor applied to cancer drug evaluation and approval.